These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38954974)

  • 1. AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer.
    Liu W; Li G; Huang D; Qin T
    Transl Oncol; 2024 Sep; 47():102027. PubMed ID: 38954974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
    Wang B; Gu Y; Hui K; Huang J; Xu S; Wu S; Li L; Fan J; Wang X; Hsieh JT; He D; Wu K
    Urol Oncol; 2018 Oct; 36(10):472.e11-472.e20. PubMed ID: 30139661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a Proteomics-Based Signature of AKR1C3-Related Genes for Predicting the Prognosis of Prostate Cancer.
    Cui X; Li C; Ding J; Yao Z; Zhao T; Guo J; Wang Y; Li J
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
    Park S; Song CS; Lin CL; Jiang S; Osmulski PA; Wang CM; Marck BT; Matsumoto AM; Morrissey C; Gaczynska ME; Chen Y; Mostaghel EA; Chatterjee B
    Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31894239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.
    Wu CH; Ko JL; Chen SC; Lin YW; Han CP; Yang TY; Chien MH; Wang PH
    Gynecol Oncol; 2014 Feb; 132(2):474-82. PubMed ID: 24316309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.
    Chang TS; Lin HK; Rogers KA; Brame LS; Yeh MM; Yang Q; Fung KM
    Int J Clin Exp Pathol; 2013; 6(11):2419-29. PubMed ID: 24228104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy.
    Wang Y; Su L; Hu Z; Peng S; Li N; Fu H; Wang B; Wu H
    Apoptosis; 2024 Oct; 29(9-10):1429-1453. PubMed ID: 39023830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells.
    Zhao J; Xiang Y; Xiao C; Guo P; Wang D; Liu Y; Shen Y
    Int J Med Sci; 2014; 11(11):1089-97. PubMed ID: 25170291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.
    Miller VL; Lin HK; Murugan P; Fan M; Penning TM; Brame LS; Yang Q; Fung KM
    Int J Clin Exp Pathol; 2012; 5(4):278-89. PubMed ID: 22670171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2α.
    Jeng KS; Cheng PY; Lin YH; Liu PC; Tseng PH; Wang YC; Chang CF; Leu CM
    Oncol Res; 2023; 32(1):163-174. PubMed ID: 38188684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flotillin1 promotes EMT of human small cell lung cancer via TGF-β signaling pathway.
    Zhao L; Li J; Liu Y; Zhou W; Shan Y; Fan X; Zhou X; Shan B; Song Y; Zhan Q
    Cancer Biol Med; 2018 Nov; 15(4):400-414. PubMed ID: 30766750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D; Yang W; Zeng Y; Li W; Wang K; Zhao L; Li J; Ye Y; Guo Q
    Cell Signal; 2021 Aug; 84():110038. PubMed ID: 33984486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy.
    Zhao J; Zhang M; Liu J; Liu Z; Shen P; Nie L; Guo W; Cai D; Liu J; Armstrong CM; Sun G; Chen J; Zhu S; Dai J; Zhang H; Zhao P; Zhang X; Yin X; Zhu X; Ni Y; Chen N; Zeng H
    Prostate; 2019 Sep; 79(13):1553-1562. PubMed ID: 31294486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T; Xu F; Xu J; Liu L; Chen Y
    Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
    Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
    Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells.
    Jamieson SM; Gu Y; Manesh DM; El-Hoss J; Jing D; Mackenzie KL; Guise CP; Foehrenbacher A; Pullen SM; Benito J; Smaill JB; Patterson AV; Mulaw MA; Konopleva M; Bohlander SK; Lock RB; Wilson WR
    Biochem Pharmacol; 2014 Mar; 88(1):36-45. PubMed ID: 24434189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma.
    Zhou Q; Tian W; Jiang Z; Huang T; Ge C; Liu T; Zhao F; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
    Cancer Res; 2021 Mar; 81(5):1361-1374. PubMed ID: 33361392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSE, positively regulated by LINC00657-miR-93-5p axis, promotes small cell lung cancer (SCLC) invasion and epithelial-mesenchymal transition (EMT) process.
    Lu L; Zha Z; Zhang P; Li D; Liu G
    Int J Med Sci; 2021; 18(16):3768-3779. PubMed ID: 34790052
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Zhu S; Ni Y; Wang Z; Zhang X; Zhang Y; Zhao F; Dai J; Wang Z; Zhu X; Chen J; Zhao J; Zeng Y; Chen N; Zeng P; Shen P; Sun G; Zeng H
    Oncologist; 2022 Nov; 27(11):e870-e877. PubMed ID: 36067250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.